Antihypertensive treatment and blood pressure control relative to hypertension treatment guidelines

2014 ◽  
Vol 23 (12) ◽  
pp. 1294-1302 ◽  
Author(s):  
Christopher G. Rowan ◽  
John Rick Turner ◽  
Ankit Shah ◽  
Jeffrey A. Spaeder
1989 ◽  
Vol 87 (3) ◽  
pp. S46-S56 ◽  
Author(s):  
Oreste De Divitiis ◽  
Salvatore Di Somma ◽  
Vincenzo Liguori ◽  
Maurizio Petitto ◽  
Carmine Magnotta ◽  
...  

Drugs & Aging ◽  
2018 ◽  
Vol 35 (11) ◽  
pp. 993-1003 ◽  
Author(s):  
Maximilian König ◽  
Maik Gollasch ◽  
Adrian Rosada ◽  
Ilja Demuth ◽  
Dominik Spira ◽  
...  

2019 ◽  
Vol 61 (2) ◽  
pp. 24-26
Author(s):  
J. A. Ker ◽  
K. Outhoff

Globally more than 1 billion people have hypertension and it is predicted that because of ageing populations and increasing sedentary lifestyles, this figure will rise to about 1.5 billion by 2025. Elevated blood pressure (BP) is the leading cause of premature death and morbidity due to stroke and ischemic heart disease. Hypertension is also a major risk factor for heart failure, atrial fibrillation, chronic kidney disease, peripheral arterial disease and cognitive decline. This article discusses the current evidencebased treatment guidelines and pressing temporal issues in optimal blood pressure control.


2007 ◽  
Vol 29 (5) ◽  
pp. 972-984 ◽  
Author(s):  
Vicki Fung ◽  
Jie Huang ◽  
Richard Brand ◽  
Joseph P. Newhouse ◽  
John Hsu

Sign in / Sign up

Export Citation Format

Share Document